Table 4 |
|||
|
Comparison of mean serum 25(OH)D levels at baseline and first follow-up stratified by top 5 cancer sites (N = 799) |
|||
|
Site of tumor |
Baseline Mean 25(OH)D in ng/mL (SD) |
Follow-up Mean 25(OH)D in ng/mL (SD) |
Paired t-test p-value |
|
|
|||
|
All Cancers (n = 799) |
19.1 (7.5) |
36.2 (17.1) |
< 0.001 |
|
|
|||
|
Breast (n = 182) |
19.7 (8.0) |
37.6 (16.8) |
< 0.001 |
|
|
|||
|
Lung (n = 120) |
18.4 (7.3) |
41.1 (18.9) |
< 0.001 |
|
|
|||
|
Pancreas (n = 60) |
16.2 (7.7) |
30.8 (14.2) |
< 0.001 |
|
|
|||
|
Colorectal (n = 90) |
18.7 (7.7) |
31.9 (16.2) |
< 0.001 |
|
|
|||
|
Prostate (n = 60) |
20.2 (6.9) |
42.1 (15.9) |
< 0.001 |
|
|
|||
|
Others (n = 287) |
19.5 (7.1) |
34.6 (16.8) |
< 0.001 |
|
|
|||
|
SD = Standard Deviation |
|||
|
Vashi et al. Nutrition Journal 2010 9:60 doi:10.1186/1475-2891-9-60 |
|||
